NLRP3 function can also be modulated through the inhibition of CYP17A1 and CYP19A1 via clotrimazole (30 mg/kg/day) [144], which produces an anti-inflammatory response and reduces depression-like behaviors. This evidence concerns the gene NLRP3 and major depressive disorder.